*Clinical–Educational Note
This article is intended for educational and scientific purposes only. It does not constitute medical advice or treatment recommendations. Content is aligned with ISSCA’s evidence-based, ethical approach to regenerative medicine education.
What are MSCs (Mesenchymal Stromal / Stem Cells)?
MSCs, commonly referred to as Mesenchymal Stem Cells or Mesenchymal Stromal Cells, are a multipotent cell population originally identified in adult bone marrow and later found in multiple tissues throughout the human body. In modern scientific literature, the term mesenchymal stromal cells is preferred, as endorsed by the International Society for Cell & Gene Therapy (ISCT), because their primary function is not always differentiation, but rather regulation, signaling, and modulation of tissue repair.
The landmark work by Pittenger et al. (Science, 1999) demonstrated that MSCs can differentiate into osteogenic, chondrogenic, and adipogenic lineages under specific experimental conditions. Later, Dominici et al. (Cytotherapy, 2006) established the international minimal criteria for defining MSCs.
Where are MSCs found in the human body?
MSCs are not restricted to a single organ. Histological and cellular biology studies have identified MSCs in multiple tissue niches, explaining their central role in regenerative medicine.
Well-documented sources include:
- Bone marrow
- Adipose tissue
- Umbilical cord and Wharton’s jelly
- Synovial tissue
- Dermis and connective tissue
- Dental pulp and perivascular regions
Arnold Caplan, one of the pioneers of the field, proposed that many MSCs function in vivo as perivascular cells, acting as sentinels of tissue damage and regulators of the inflammatory microenvironment.
Why are MSCs considered key in regenerative medicine?
For many years, the therapeutic value of MSCs was attributed mainly to their differentiation capacity. However, the most robust evidence from the past decade indicates that their primary role is paracrine and immunomodulatory.
MSCs are known to:
- Modulate innate and adaptive immune responses
- Secrete trophic and growth factors
- Reduce apoptosis in injured tissues
- Promote angiogenesis and tissue remodeling
- Influence fibrosis and scar formation
For this reason, Caplan proposed redefining MSCs as “Medicinal Signaling Cells”, emphasizing their role in orchestrating repair rather than directly replacing damaged tissue.
How do MSCs act at the cellular and molecular level?
MSCs respond to injury-related signals such as hypoxia, inflammation, and oxidative stress. Once activated, they secrete a wide range of bioactive molecules, including:
- Anti-inflammatory cytokines
- Growth factors (VEGF, TGF-β, HGF)
- Extracellular vesicles and exosomes
- Immunoregulatory molecules
These signals directly influence the tissue microenvironment, creating conditions that support endogenous repair and regeneration.
What does the scientific evidence say about MSCs?
The body of scientific literature on MSCs is among the most extensive in regenerative medicine. Key milestones include:
- Pittenger et al., Science (1999): demonstration of multilineage differentiation
- Dominici et al., Cytotherapy (2006): minimal criteria for MSC identification (CD105+, CD73+, CD90+, CD45−)
- Caplan, Stem Cells Translational Medicine (2017): functional redefinition of MSCs as signaling cells
- Viswanathan et al., Cytotherapy (2019): clarification of nomenclature and clinical manufacturing standards by ISCT
These publications highlight the importance of standardization, characterization, and quality control in both research and clinical translation.
In which clinical areas are MSCs being studied today?
MSCs are currently under investigation in a wide range of medical contexts, including:
- Orthopedics and musculoskeletal injuries
- Osteoarthritis and joint disorders
- Chronic inflammatory diseases
- Sports medicine
- Neurology and ischemic injury
- Aesthetic and skin regeneration
It is critical to distinguish between clinical research, compassionate use, and approved medical applications, avoiding unsupported extrapolations.
Frequently Asked Questions (FAQ)
Are MSCs embryonic stem cells?
No. MSCs are adult cells and do not involve embryonic ethical concerns.
Are all MSCs the same?
No. Their behavior depends on tissue source, isolation method, and biological context.
Do MSCs always differentiate into new tissue?
Not necessarily. Their most consistently demonstrated effect is paracrine and immunomodulatory.
Are MSCs approved for all clinical uses?
No. Many applications remain investigational and must comply with local and international regulations.
Conclusion
MSCs represent one of the biological pillars of modern regenerative medicine. Their true value lies not only in differentiation, but in their ability to orchestrate tissue repair through signaling, immune modulation, and microenvironment support.
Understanding what MSCs truly are—and what they are not—is essential for advancing responsible, effective, and scientifically grounded regenerative medicine. At ISSCA, this understanding is the foundation of all clinical and academic training.
